In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Cancer therapeutics company Cyclacel Ltd. raised £21.3mm ($39mm) in an oversubscribed Series D private placement. New investors included Societé Generale Asset Management, Carnegie Fund, DC Thomson, NIF Ventures, Quest for Growth, and UOB Venture Technology Investments.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?